The score is primarily held back by sharp deterioration in financial performance (large losses, margin collapse, and renewed cash burn) alongside rising leverage. Technicals provide some support (price above key moving averages with neutral momentum), but valuation is not supportive due to ongoing losses and no dividend yield.
Positive Factors
Historic margin recovery potential
Prior years (notably 2022) produced healthy gross margins and meaningful revenue, indicating the underlying business model and market position can support profitable operations when demand or pricing normalizes. That track record suggests upside if cost structure or pricing stabilizes, aiding medium-term recovery.
Equity cushion remains
Positive equity and a balance-sheet cushion mean the company still has a capital buffer to absorb losses and pursue restructuring or financing alternatives. This reduces immediate solvency risk and gives management time (2–6 months) to implement operational fixes or secure transitional funding without imminent insolvency pressure.
Demonstrated cash generation in good years
The firm has previously converted revenue into strong operating and free cash flow in favorable periods, showing the business can generate self-funded growth under the right conditions. That historical cash-conversion ability supports the view that operational improvements could restore internal funding capacity over the medium term.
Negative Factors
Sharp revenue and margin deterioration
A 20% revenue decline alongside a collapse to ~3% gross margin indicates material demand, pricing, or cost-absorption issues. Operating losses that exceed revenue suggest core profitability has broken down, reducing the firm’s ability to self-fund operations and increasing the risk that structural fixes will be required to restore sustainable margins.
Persistent negative cash flow
Repeated negative operating and free cash flow raises the probability of near-term funding needs. Persistent cash consumption limits reinvestment, forces reliance on external financing, and can trigger dilutive capital raises or higher-cost debt, constraining the company’s ability to execute strategic plans and recover margins.
Rising leverage and capital erosion
Rapidly rising debt-to-equity and stepped-down assets/equity signal erosion of the capital base and increased solvency risk. Higher leverage narrows financial flexibility, raises funding costs, and could force asset sales or restructuring if losses persist, undermining competitive position and long-term resilience.
Harvest Minerals (HMI) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£1.64M
Dividend YieldN/A
Average Volume (3M)722.48K
Price to Earnings (P/E)―
Beta (1Y)-0.42
Revenue GrowthN/A
EPS GrowthN/A
CountryUK
Employees4
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding503,169,220
10 Day Avg. Volume127,775
30 Day Avg. Volume722,484
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)0.51
Price to Sales (P/S)0.87
P/FCF Ratio-5.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Harvest Minerals Business Overview & Revenue Model
Company DescriptionHarvest Minerals Limited engages in the mineral exploration and production of organic natural fertilizers in Brazil. It holds 100% interests in the Arapua fertilizer project located in the state of Minas Gerais in Brazil; the Mandacaru phosphate project comprising three exploration licenses covering an area of 5,908.67 hectares located in the Ceara State, Brazil; and the Sergi potash project located in the Sergipe State, Brazil. The company was formerly known as Triumph Tin Limited and changed its name to Harvest Minerals Limited in December 2014. Harvest Minerals Limited was incorporated in 2010 and is based in Perth, Australia.
How the Company Makes Money
Harvest Minerals Financial Statement Overview
Summary
Financial performance is weak. Revenue fell ~20% in 2024, profitability deteriorated into large losses (with operating losses exceeding revenue), and gross margin collapsed to ~3% in 2024. Cash flow is also pressured, with negative operating cash flow and worsening free cash flow in 2024, increasing funding risk. The balance sheet still has positive equity, but leverage has risen quickly (debt-to-equity ~0.70 in 2024).
Income Statement
18
Very Negative
Profitability has deteriorated sharply. Revenue fell ~20% in 2024 and the company moved from a modest profit in 2022 to large losses in 2023–2024, with operating losses that are bigger than revenue and a very low gross margin in 2024 (~3% vs ~47% in 2023). The main positive is that the business has shown it can generate meaningful revenue and healthy gross margins in prior years (notably 2022), but the recent trajectory is clearly negative and suggests weak cost absorption and/or pricing pressure.
Balance Sheet
44
Neutral
The balance sheet is mixed but weakening. Equity remains positive, but leverage has risen quickly: debt-to-equity increased to ~0.70 in 2024 from ~0.38 in 2023 and near-zero in 2020–2022. Returns on equity are deeply negative in 2023–2024 due to net losses, and total assets and equity have both stepped down versus 2023, pointing to erosion of the capital base. Strength: the company is not yet over-levered on this measure and still has a meaningful equity cushion; weakness: the pace of debt build and losses increases financial risk.
Cash Flow
26
Negative
Cash generation is weak and volatile. Operating cash flow was negative in 2024 and free cash flow has been negative in most years (2020, 2021, 2023, 2024), with 2024 free cash flow worsening materially versus 2023. While 2022 showed strong operating cash flow and positive free cash flow, the more recent pattern suggests the business is consuming cash as losses persist, raising the likelihood of additional funding needs.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 04, 2026